April 28, 2020 / 12:37 PM / in a month

BRIEF-Therapix Biosciences obtains extension to regain compliance with Nasdaq listing requirements

April 28 (Reuters) - Therapix Biosciences Ltd:

* NASDAQ HEARINGS PANEL GRANTS THERAPIX BIOSCIENCES EXTENSION TO REGAIN COMPLIANCE WITH LISTING REQUIREMENTS

* THERAPIX BIOSCIENCES: NASDAQ HEARINGS PANEL GRANTS THERAPIX EXTENSION TO REGAIN COMPLIANCE WITH LISTING REQUIREMENTS

* THERAPIX SAYS IT HAS RECEIVED AN EXTENSION UNTIL MAY 18

* THERAPIX SAYS IT WILL HAVE UNTIL NOVEMBER 5 TO REGAIN COMPLIANCE WITH BID PRICE RULE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below